10.1 C
Delhi
Monday, January 17, 2022

Corona case across 50 lakhs in India; Vaccine Trial to Serum Institute

Coronavirus cases, Vaccine updates 

Today in the world, India is the country where the maximum cases of corona are coming daily. A relieving aspect in this is also that the recovery rate in India is the highest and the death rate is the lowest. The recovery rate is more than 78 percent and the death rate is below 1.65 percent. At the same time, in the case of testing, India is second after the US.

However, it is worrying that on an average, more than 90 thousand new corona cases are coming in the country every day. According to the Health Ministry, 90,123 new cases of coronavirus occurred in the last 24 hours and 1290 people died. The world, including India, is focused only on the Covid-19 vaccine. There is also good news that the Serum Institute of India (SII) has been approved by DCGI to resume the clinical trial of Oxford’s COVID 19 vaccine.

The Controller General of Indian Medicine (DCGI) directed the Serum Institute of India to stop the clinical trial of a potential vaccine for Covid-19. Because the drug company AstraZeneca stopped the trial of a volunteer involved in the trial after a health condition deteriorated. Oxford is developing the vaccine in collaboration with pharmaceutical company AstraZeneca.

Read: What to do, not what to do after recovering from corona; Ministry of Health

Over 50 lakh cases in India

According to data from the Union Ministry of Health and Family Welfare, till 8 am on September 16, 90,123 new COVID 19 cases and 1,290 deaths have occurred in India in the last 24 hours. The total number of positive cases in the country has increased to 50,20,360. Out of this, there are 9,95,933 active cases, while 39,42,361 people have been recovered. Corona has killed 82,066 people in the country so far.

According to the Indian Council of Medical Research (ICMR), a total of 5,94,29,115 sample tests were conducted for the coronavirus by September 15, of which 11,16,842 samples were tested yesterday. In the world of testing, India is at the second position. America has done more than 9.36 crore tests so far.

Meet Yash Tiwari, an 18-year-old international youth mentor who wrote the world’s first novel on Corona Pandemic

A clinical trial of 3 vaccines in India

Earlier, Director General of ICMR Prof. Balaram Bhargava told that three vaccines in India are at the clinical trial stage. Cadila and Bharat Biotech have completed the first phase of TRAIL. The Serum Institute has completed the Phase 2B3 trial. Now she will start Phase 3 trials on 1500 people on 14 sites.

The most active cases in India are coming from five states. According to the Ministry of Health, there are 5 states in the country in which 60 percent of the total active cases of the country are cases. Of the total active cases across the country, Maharashtra has more than 29%, Andhra Pradesh about 9%, Karnataka about 10%, Uttar Pradesh 6.8% and Tamil Nadu about 4.7%.

Plasma therapy may be safe, even effective for children with corona: study

Serum Institute approved for testing again

Meanwhile, one of the reliefs on the Corona vaccine is that Controller General of Indian Medicine (DCGI) Dr VG Somani has approved the Serum Institute of India (SII) to resume the clinical trial of Oxford’s COVID 19 vaccine. The Serum Institute is preparing the Oxford University vaccine in India along with Estrogenica of Britain.

DCGI has withdrawn its earlier order restraining the selection of any candidate for the second and third stage trials. However, the regulator has kept many other conditions for this, including the sharing of information to pay extra attention during the investigation. The Serum Institute has also been asked to submit information about the treatment prescribed as per rules in dealing with adverse situations.

Job lost in Covid-19? Now this government scheme will be available by 30 June 2021

 

Source: www.financialexpress.com

#Corona #case #lakhs #India #Vaccine #Trial #Serum #Institute

Bhagyashree Soni
Bhagyashree Soni is a software engineer with soft writing skills. She is a degree holder from the International School of Entrepreneurial Leadership. She has been a state-level badminton champion and chess player. A woman with a forthright attitude enjoys her writing passion as her chosen career. Writing in the context of feminism, social cause and entrepreneurship is her forte.
Latest news
- Advertisement -
Related news
- Advertisement -